Tavalisse Tablet
Product Images NDC 71332-002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tavalisse (NDC 71332-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rigel Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tavalisse 01)

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
The text "ocTana Rxonly" does not provide any useful information. "Tovalisse" appears to be the name of a drug called "fostomatinib" which is likely available in tablet form with 60 tablets per package.*
FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Principal Display Panel (150 mg Tablet Bottle Label)
Tovalisse is a medication available only with a prescription that comes in the form of fostamatinib tablets. The text "wocanea" cannot be identified and may contain non-English characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.